ChIP-Sequence

Credit: © 2008 Illumina Inc. All Rights Reserved." /> Credit: © 2008 Illumina Inc. All Rights Reserved. Researcher: Steven Jones, head, Bioinformatics, Genome Sciences Center, British Columbia Cancer Research Center, Vancouver, BC, Canada Project: Mapping transcription-factor binding in interferon-gamma-stimulated and unstimu

Written byJeffrey M. Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researcher:

Steven Jones, head, Bioinformatics, Genome Sciences Center, British Columbia Cancer Research Center, Vancouver, BC, Canada

Project:

Mapping transcription-factor binding in interferon-gamma-stimulated and unstimulated human cells.

Problem:

Though the yeast genome fits on a single array, most mammalian genomes do not. How, then, does one analyze transcription-factor binding across the entire genome?

Solution:

Jones and his team took the DNA output from ChIP and sequenced it using an Illumina 1G Genome Analyzer, generating 47 million 27-bp reads, or about 1.27 GB of sequence data. Though others had tried sequencing ChIP'd DNA, using either Sanger sequencing or Roche's 454 technology, the depth of coverage was always limited, says Jones. The 1G yields shorter runs, but more of them. "That was the paradigm shift in our ability to map protein-DNA interactions in mammalian-sized genomes," he says.

Jones notes that ChIP is just an enrichment strategy; DNA that was not bound ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies